Kidney oncocytoma
diseaseOn this page
Also known as kidney oncocytic neoplasmoncocytoma kidneyoncocytoma of kidneyoncocytoma of the kidneyoncocytoma renalrenal epithelial oncocytic neoplasmrenal epithelial oncocytic tumorrenal epithelial oncocytic tumourrenal oncocytomaROCY
Summary
Kidney oncocytoma (MONDO:0003825) is a disease and 3 clinical trials. Top therapeutic interventions include pazopanib hydrochloride. A subtype of kidney benign neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 3
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | kidney oncocytoma |
| Mondo ID | MONDO:0003825 |
| MeSH | C537750 |
| DOID | DOID:6245 |
| NCIT | C4526 |
| SNOMED CT | 254922006 |
| UMLS | C0346255 |
| MedGen | 91094 |
| Anatomy (UBERON) | UBERON:0002113 |
| Is cancer (heuristic) | no |
Also known as: kidney oncocytic neoplasm · kidney oncocytoma · oncocytoma kidney · oncocytoma of kidney · oncocytoma of the kidney · oncocytoma renal · renal epithelial oncocytic neoplasm · renal epithelial oncocytic tumor · renal epithelial oncocytic tumour · renal oncocytoma · ROCY
Disease family
This is a subtype of kidney benign neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › benign neoplasm › benign urinary system neoplasm › kidney benign neoplasm › kidney oncocytoma
Related subtypes (11): kidney lipoma, benign cystic nephroma, renal adenoma, nephrogenic adenofibroma, nephrogenic adenoma, kidney angiomyolipoma, renal leiomyoma, benign metanephric tumor, benign neoplasm of renal pelvis, benign mesonephroma, nephroma
Subtypes (1): hereditary kidney oncocytoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 3.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 2 |
| PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT01767636 | PHASE2 | COMPLETED | Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer |
| NCT06339138 | Not specified | ACTIVE_NOT_RECRUITING | Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study |
| NCT00898365 | Not specified | COMPLETED | Study of Kidney Tumors in Younger Patients |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| PAZOPANIB HYDROCHLORIDE | 4 | 1 |
Related Atlas pages
- Drugs: Pazopanib